UK Sees Sharp Rise in COVID-19 Hospitalizations Amid Early Flu Surge
Health officials urge vaccinations as COVID-19 hospital admissions climb over 40% in two weeks, coinciding with an unusually early increase in flu cases.
COVID-19 hospital admissions in the United Kingdom have surged by more than 40% over the past two weeks, with experts warning of a potential winter crisis due to an early and significant rise in flu cases. Recent data indicates a substantial increase in patients requiring hospital care for the virus, alongside a notable uptick in COVID-19 deaths.
New statistics from the UK Health Security Agency (UKHSA) show that approximately 2.46 out of every 100,000 people are now being admitted to hospitals with COVID-19 weekly. This represents a nearly 41% increase from two weeks prior, when the rate was 1.75 per 100,000. The West Midlands currently reports the highest admission rate, with around 3.55 cases per 100,000, while the South West has the lowest at approximately 1.5 per 100,000.
Separate figures reveal a 46.4% rise in COVID-19 deaths in the week leading up to October 2, increasing from 28 to 41. Individuals aged 85 and over remain the most vulnerable group, with nearly 27 admissions per 100,000 population, a rate more than ten times the national average. Approximately 13.5% of this age group are testing positive for COVID-19.
Experts have expressed concern about the early onset of respiratory illnesses. Professor Frankie Swords, National Medical Director at NHS England, has noted "ominous early signs of winter pressure." The increase in flu cases is also a significant concern, with positive flu tests last month reportedly double those recorded in September of the previous year. Dr. Adam Finn, emeritus professor of paediatrics at the University of Bristol, highlighted that flu activity typically does not become noticeable until December, making the current September surge unusually early. He suggested that reduced population immunity due to COVID-19 lockdowns, which limited exposure to other respiratory infections, could be a contributing factor.
While flu hospital admissions remained stable at 1.88 per 100,000 population last week, totaling around 1,070 admissions weekly, officials are emphasizing the importance of vaccination. Dr. Jamie Lopez Bernal, consultant epidemiologist at the UKHSA, urged eligible individuals to get vaccinated against both flu and COVID-19, citing the rising flu levels and the possibility of an early flu season.
The flu vaccine is designed to protect against the three main circulating strains: two subtypes of influenza A (H1N1 and H3N2) and influenza B. However, the UKHSA cautioned that genetic changes, or 'drift,' in some flu strains could potentially reduce vaccine effectiveness. Recent reports indicate the presence of 'drifted' AH1N1 viruses in Europe, including the UK.
The primary COVID-19 strain currently circulating is known as XFG, or 'Stratus,' which has been prevalent in North America and Europe since late 2025. UKHSA officials stated that these strains are closely related to those that have been circulating for over a year and that there is no evidence suggesting they are causing more severe illness or spreading faster. This year's autumn COVID-19 vaccine has been specifically formulated to offer protection against these strains.